𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A Novel Orally Active Inhibitor of HLE.

✍ Scribed by Marton Varga; Zoltan Kapui; Sandor Batori; Lajos T. Nagy; Lelle Vasvari-Debreczy; Endre Mikus; Katalin Urban-Szabo; Peter Aranyi

Book ID
101946767
Publisher
John Wiley and Sons
Year
2003
Weight
108 KB
Volume
34
Category
Article
ISSN
0931-7597

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A novel nonpeptidic, orally active renin
A novel nonpeptidic, orally active renin inhibitor
✍ Hajime Morishima; Yutaka Koike; Masato Nakano; Shugo Atsuumi; Seiichi Tanaka; Hi πŸ“‚ Article πŸ“… 1989 πŸ› Elsevier Science 🌐 English βš– 361 KB
Preclinical progress with CHF2819, a nov
Preclinical progress with CHF2819, a novel orally active acetylcholinesterase inhibitor
✍ Tommaso Cassano; M. Rosaria CarratΓΉ; Addolorata Coluccia; Vincenzo Di Giovanni; πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 211 KB

## Abstract (‐)‐(3aS,8aS,1S)‐1,2,3,3a,8,8a‐hexahydro‐1,3a,8‐trimethylpyrrolo[2,3‐b]indol‐5‐ol‐2′‐ethylphenylcarbamate N‐oxide hydrochloride (CHF2819) is a novel, orally active acetylcholinesterase inhibitor (AChEI) for Alzheimer's disease (AD). CHF2819 appears as a selective inhibitor of AChE, bein